Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Tzyy‐Jer Hsu"'
Autor:
Chia‐Pin Lin, Tzyy‐Jer Hsu, Ying‐Chang Tung, Fu‐Chih Hsiao, Shing‐Hsien Chou, Yu‐Sheng Lin, Shao‐Wei Chen, Pao‐Hsien Chu
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 9 (2024)
Background Hypertension and hypercholesterolemia are important risk factors for cardiovascular disease, and treatment with fixed‐dose combination (FDC) regimens is recommended by current guidelines. However, the clinical outcomes of different FDC d
Externí odkaz:
https://doaj.org/article/b88f5954fc27491693f22c68fcec8ab7
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2784-2796 (2020)
Abstract Aims Recent studies indicated that sodium glucose cotransporter‐2 inhibitors (SGLT2i) reduced heart failure hospitalization in patients with type 2 diabetes mellitus (T2DM). However, whether SGTL2i can improve left ventricular (LV) systoli
Externí odkaz:
https://doaj.org/article/dbd8c112e29d4c7daed55ebfb1313840
Autor:
Ying-Chang Tung, Fu-Chih Hsiao, Chia-Pin Lin, Chien-Te Ho, Tzyy-Jer Hsu, Hou-Yu Chiang, Pao-Hsien Chu
Publikováno v:
American Journal of Gastroenterology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b5cc2d99914e7c4b6ffec7c25ef3727
https://doi.org/10.14309/ajg.0000000000002198
https://doi.org/10.14309/ajg.0000000000002198
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2784-2796 (2020)
Aims Recent studies indicated that sodium glucose cotransporter‐2 inhibitors (SGLT2i) reduced heart failure hospitalization in patients with type 2 diabetes mellitus (T2DM). However, whether SGTL2i can improve left ventricular (LV) systolic and dia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f57e10f6c83ced3331d3ce8a25dc62a
https://doaj.org/article/dbd8c112e29d4c7daed55ebfb1313840
https://doaj.org/article/dbd8c112e29d4c7daed55ebfb1313840
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac55e5fc3d3425911f73e78f2c4136d9
https://doi.org/10.2139/ssrn.4214536
https://doi.org/10.2139/ssrn.4214536
Autor:
Ying‐Chang Tung, Tzyy‐Jer Hsu, Chia‐Pin Lin, Fu‐Chih Hsiao, You‐Chia Chu, Wen‐Jone Chen, Pao‐Hsien Chu
Publikováno v:
J Clin Hypertens (Greenwich)
The cover image is based on the Original Article Efficacy and safety outcomes of one generic nifedipine versus ADALAT long‐acting nifedipine for hypertension management by Ying‐Chang Tung et al., https://doi.org/10.1111/jch.14070. [Image: see tex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109c31313f9c6d58321e76bf329f296f
https://doi.org/10.1111/jch.14139
https://doi.org/10.1111/jch.14139
Autor:
Fu-Chih Hsiao, You-Chia Chu, Pao-Hsien Chu, Ying-Chang Tung, Tzyy-Jer Hsu, Wen-Jone Chen, Chia-Pin Lin
Publikováno v:
J Clin Hypertens (Greenwich)
Data regarding the long-term outcomes of generic antihypertensive drugs are limited. This nationwide retrospective database analysis aimed to evaluate the efficacy and safety of a generic versus brand-name nifedipine for hypertension treatment. Patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36f24a1d65b74e3efb8b33531a9560a5
https://europepmc.org/articles/PMC8029800/
https://europepmc.org/articles/PMC8029800/
Autor:
Tung, Ying‐Chang, Lin, Chia‐Pin, Hsiao, Fu‐Chih, Ho, Chien‐Te, Tzyy‐Jer, Hsu, Chu, You‐Chia, Chen, Wen‐Jone, Chu, Pao‐Hsien
Publikováno v:
Journal of Clinical Hypertension; May2022, Vol. 24 Issue 5, pi-i, 1p